Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

American Society of Hematology (ASH 2026) 12 - 15 December 2026

Treatment continuity, healthcare resource utilization, and healthcare costs among patients newly initiating disease-modifying treatments for sickle cell disease

Authors :

Elnara Fazio-Eynullayeva, MA1; Brenna Brady, PhD2; Megan Richards, PhD2; E. Leila Jerome Clay, MD1; Biree Andemariam, MD3

Affiliations
View Details Hide Details
Keywords
Rare Blood Disorders
Congress oral presentation
Rare Bleeding Disorders
Pipeline
RWE